98%
921
2 minutes
20
Objective: To determine the accuracy of ultrasound in the assessment of proximal fallopian tube positioning of the Essure microinsert coil 3 months after postprocedure.
Design: Prospective cohort study (Canadian Task Force classification II-2).
Setting: Reproductive-age women in a tertiary care hospital.
Patient(s): Reproductive-age women presenting with a request for permanent contraception.
Intervention(s): Hysteroscopic sterilization with the Essure microinsert coil and conventional or volume-contrast three-dimensional (3D) ultrasound imaging 3 months after the procedure.
Main Outcome Measure(s): Coil position on ultrasound.
Result(s): Forty-eight of the 50 patients had successful placement of the Essure coils, and three patients required a second attempt on one tube. Conventional or volume-contrast (3D) ultrasound showed proper positioning of the coils within the proximal fallopian tube in 42 women (84%); five women (10%) required hysterosalpingogram to show appropriate positioning. Two patients (4%) required laparoscopic tubal sterilization, and one patient (2%) was lost to follow-up.
Conclusion(s): Transvaginal ultrasound is an acceptable method of confirming proper placement of the Essure microinsert coil within the proximal fallopian tube 3 months after the procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.fertnstert.2005.01.135 | DOI Listing |
J Gynecol Obstet Hum Reprod
November 2024
Department of Gynecology, Hôpital Femme Mère Enfant, HFME, University Hospital of Lyon, 59 boulevard Pinel, Lyon 69000, France.
BMC Womens Health
June 2022
Department of General Gynaecology and Urogynaecology, Clinic for Gynaecology and Perinatology, University Medical Centre Maribor, Ljubljanska 5, 2000, Maribor, Slovenia.
Background: The objective of our study was to assess the rate and causes for Essure® micro-insert system removal and patients' long term satisfaction rate with the procedure.
Methods: All patients who underwent Essure® hysteroscopic sterilization at our tertiary centre between years 2007 and 2018 were included in this follow-up study. A questionnaire was sent to all patients per standard mail.
Am J Case Rep
April 2022
Department of Reproductive Endocrinology & Infertility, University of Cincinnati, College of Medicine, West Chester, OH, USA.
BACKGROUND Interstitial ectopic pregnancy, a pregnancy occurring in the part of the fallopian tube that is within the body of the uterus, poses a significant risk to patients, with a mortality rate of up to 2.5%, which is 7 times higher than for tubal ectopic pregnancies. Hysteroscopic sterilization reversal carries a potential risk of interstitial ectopic pregnancy; therefore, it is important to counsel patients appropriate and review the alternative option for in vitro fertilization.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
August 2021
Department of Obstetrics and Gynecology, Maastricht University Medical Centre+, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands. Electronic address:
Objective: To analyze perioperative findings and complications in surgical removal of Essure® microinserts.
Study Design: A prospective cohort study of 274 patients who underwent surgical removal of Essure® microinserts. Outcomes of the surgical procedures and complications were entered into a digital case report form (CRF) by the surgeon and registered in an online database.
Eur J Contracept Reprod Health Care
October 2021
Department of Gynecology, Institut Mère Enfant Alix de Champagne, University hospital of Reims, Reims, France.
Purpose: To evaluate the different techniques for Essure microinserts removal and to assess the risk of fracture of the device and the intra- and post-operative complications in relation to surgical technique variants.
Methods: Electronic search in Medline, Scopus and Embase databases using the following keywords: Essure; Essure removal; Essure surgical technique.
Results: Out of 95 articles in the initial database, 17 studies were eligible for inclusion in our literature review.